Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved?
Diagnosis and treatment of functioning and non-functioning neuroendocrine tumors is a challenging task. Surgeru remains the only radical method of treatment of these tumors, but tumors often are diagnosed at the stage of metastasis, when only palliative treatment is possible. Octreotide in patients...
Saved in:
Main Author: | L. Yu. Morgunov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2015-06-01
|
Series: | Исследования и практика в медицине |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/64 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structured reporting of neuroendocrine tumors in PET/CT using [18F]SiTATE - impact on interdisciplinary communication
by: Anna Hinterberger, et al.
Published: (2025-02-01) -
Efficacy and predictors of response to somatostatin analogues in patients with ectopic ACTH syndrome
by: Olga O. Golounina, et al.
Published: (2024-12-01) -
Does treatment with somatostatin analogs differ in the uptake of normal target organs and malignant lesions on 68Ga-DOTATATE PET/CT imaging?
by: Çağlagül Erol, et al.
Published: (2022-08-01) -
A Case of Persistent Hypoglycemia: Emphasizing the Role of Kidneys
by: Praveen Govindaraju, et al.
Published: (2024-04-01) -
A large-cell neuroendocrine carcinoma in the extrahepatic bile duct: A case report and literature review
by: Jing Li, et al.
Published: (2025-02-01)